Feds probe tip that Pfizer delayed announcing COVID vaccine's success until after 2020 election: report

Group 1 - Federal prosecutors in Manhattan are investigating a claim by GSK that Pfizer delayed announcing the success of its COVID vaccine until after the 2020 election [1][4] - GSK's former head of vaccine development, Philip Dormitzer, allegedly informed GSK colleagues about the delay, although he has disputed this account [1][2] - The US Attorney's Office has interviewed at least two individuals, including a GSK executive who documented a conversation with Dormitzer, and plans to interview a third person soon [3][5] Group 2 - President Trump previously claimed that Pfizer withheld positive data from vaccine clinical trials, but there has been no evidence to support this accusation [3][5] - Pfizer officials have not yet been interviewed by the prosecutors regarding the claims made by GSK [5][6] - GSK has chosen not to comment on the ongoing investigation, while Pfizer and the US Attorney's Office have not responded to requests for comments [6]